Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Yonghao Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2676-3327; OpenAlex author ID A5101384861. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. TRIM29 may facilitate progression of pancreatic ductal adenocarcinoma through immune remodeling. First author DOI 10.1016/j.pan.2026.10.006↗
  2. Bacteria and tumor debris induced pancreatic cancer progression via the NF-κB signaling pathway. First author DOI 10.1016/j.canlet.2025.217964↗
  3. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation. Co-author DOI 10.1016/j.pan.2023.10.021↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuaiwu Luo · 1 shared paper, 2026 · strength 0.28
  2. Jun Yang · 1 shared paper, 2026 · strength 0.28
  3. Pengcheng Zhou · 1 shared paper, 2026 · strength 0.28
  4. Linquan Wu · 1 shared paper, 2026 · strength 0.28
  5. Qi Chen · 1 shared paper, 2025 · strength 0.27
  6. Tingbo Liang · 1 shared paper, 2025 · strength 0.27
  7. Tingbo Liang · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.